The immunohistochemical test showed a diffuse CK7+ (10) and apomucines MUC5AC (11) and MUC6 (12) positivity in more than 50% of neoplastic cells

The immunohistochemical test showed a diffuse CK7+ (10) and apomucines MUC5AC (11) and MUC6 (12) positivity in more than 50% of neoplastic cells. == Physique 10. in papillary masses with bile duct obstruction and dilatation. Papillary tumors generally produce a large amount of mucin and so they may occasionally impede the flow of the bile juice and cause a severe ductal dilatation. Intraductal papillary neoplasm of the liver (IPNL) is usually a recently acknowledged entity frequently reported in association with hepatolithiasis and resembling intraductal papillary mucinous tumor (IPMT) of the pancreas, in terms of its histopathology, pathophysiology, and excessive mucin production [1-5]. == Case statement == A 67-year-old Caucasian man underwent an ultrasound investigation because he suffered from right upper quadrant subcontinuous abdominal pain. The ultrasound examination and the successive Computed Tomography (CT)-examination, this Alvelestat last performed using an Aquilion 64 slice (Toshiba Medical System, Zoetmeer, Netherlands) revealed a solid, focal mass, about 3 cm in diameter, at the V hepatic segment in Alvelestat the presence of diffuse steatosis. On CT the mass offered hypodense respect to the surrounding tissue during the basal phase (Physique1) and with a light peripherical enhanced rim in the arterial phase that increased in the portal venous phase. (Physique2,3) In late phase, the lesion showed a puntacte aspect because of the presence of intralesional hypervascular spots. (Physique4) The bile ducts did not appear dilatated. == Physique 1. == Transverse CT scan. It reveals a solid focal mass, about 3 cm in diameter, hypodense respect to the surrounding tissue in the basal phase (1) with a light peripherical enhanced rim in the arterial phase (2) that increases in the portal venous phase (3). In late Alvelestat phase (4), the lesion shows a puntacte aspect because of the presence of intralesional hypervascular spots (arrow). The bile ducts are not dilatated. == Physique 2. == Transverse CT scan. It reveals a solid focal mass, about 3 cm in diameter, hypodense respect to the surrounding tissue in the basal phase (1) with a light peripherical enhanced rim in the arterial phase (2) that increases in the portal venous phase (3). In late phase (4), the lesion shows a puntacte aspect because of the presence of intralesional hypervascular spots (arrow). The bile ducts are not dilatated. == Physique 3. == Transverse CT scan. It reveals a solid focal mass, about 3 cm in diameter, hypodense respect to the surrounding tissue in the basal phase (1) with a light peripherical enhanced rim in the arterial phase (2) that increases in the portal venous phase (3). In late phase (4), the lesion shows a puntacte aspect because of the presence of intralesional hypervascular spots (arrow). The bile ducts are not dilatated. Alvelestat == Physique 4. == Transverse CT scan. It reveals a solid focal mass, about 3 cm in diameter, hypodense respect to the surrounding tissue in the basal phase (1) with a light peripherical enhanced rim in the arterial phase (2) that increases in the portal venous phase (3). In late phase (4), NR4A3 the lesion shows a puntacte aspect because of the presence of intralesional hypervascular spots (arrow). The bile ducts are not dilatated. The patient was admitted to the medical department of our hospital for further investigation. On admission, physical examination and laboratory findings were normal (included negative hepatitis B and C biomarkers), showing only a mild increase of alpha-feto-protein (73 IU/mL). At this time, the patient underwent a upper abdominal Magnetic Resonance (MR) investigation, performed Alvelestat with a Eclipse 1.5 T (Picker-Marconi, Philips, Eindhoven, Netherlands) which showed the mass hypointense in T1 W unenhanced images and slightly dishomogeneous hyperintense in sequences with long TR. (Figure5) After administration of paramagnetic contrast agent, the lesion presented the same dynamic behaviour as on CT including the appearance of intralesional hypervascular spots in late phase. (Figure6) == Figure 5. == Transverse RM scan. It reveals a slightly dishomogeneous hyperintense mass in sequences.